AstraZeneca to build new Covid-19 vaccine facility in Germany
AstraZeneca has unveiled plans to build a new Covid-19 vaccine manufacturing facility in partnership with IDT Biologika at the German firm’s Dessau site, in a move aiming to speed up production and defuse a row with the EU over vaccine supply.
View the full story here: https://www.msn.com/en-gb/money/other/astrazeneca-to-build-new-covid-19-vaccine-facility-in-germany/ar-BB1dzxz9